73969-8
LaboratoryFetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Definition
The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
LOINC 6-Axis Classification
Component
Fetal trisomy 13 risk
Property
Likelihood
Time Aspect
Pt
System
Plas.cfDNA
Scale Type
Qn
Method Type
Dosage of chromosome specific cf DNA
Details
Class
MOLPATH.TRISOMY
Order/Observation
Both
Short Name
Fet Ts 13 risk Plas.cfDNA Qn
Display Name
Trisomy 13 risk Dosage of chromosome-specific cfDNA Qn (cfDNA)
Related Names
Frequently Asked Questions
What is LOINC code 73969-8?
LOINC code 73969-8 identifies "Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA". The probability risk for trisomy 13 can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal sex chromosome aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.
What does 73969-8 measure?
This code measures Fetal trisomy 13 risk in Plas.cfDNA. It belongs to the MOLPATH.TRISOMY class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.